Jeff Bird - Profile and Investment Details

Investor Profile

Jeff Bird is a Venture Capital, Private Equity Firm, Investor based in Palo Alto, California, United States with a diverse investment portfolio that includes companies such as Stanford Health Care, GRAIL, Inc., Teneobio, Inc., Bluebird Ventures, Portola Pharmaceuticals, Leyden Labs, Foresight Dx, Procyrion, Inc., Forty Seven, Inc., HELIX, Epirium, Nutcracker Therapeutics, Gilead Sciences, Kriya Therapeutics, . Over time, Jeff Bird has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jeff Bird is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Telecommunications, Wellness, Enterprise Software, Fundraising, Investment Management, Strategic Partnerships, Portfolio Management, Startups, Due Diligence Services, Cloud Computing, Business Development, Finance, Software, Biotechnology, Sourcing, Market Research, Entrepreneurship, Innovation, Disruptive technology, Consumer Software, Hardware, UK Startups, Web Development, Developer Tools, SaaS, Big Data, Information Technology, B2B, Therapeutics, Financial Analytics may find it worthwhile to explore potential connections with Jeff Bird, as their portfolio suggests a familiarity and interest in this area.

Understanding Jeff Bird’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.